CIBC Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

CIBC Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$459K	Sell	1,904 -95	-5%	-$20.8K	﹤0.01%	857
2026 Q1	$378K	Hold	1,999	–	–	﹤0.01%	884
2025 Q4	$340K	Hold	1,999	–	–	﹤0.01%	908
2025 Q3	$263K	Hold	1,999	–	–	﹤0.01%	996
2025 Q2	$212K	Sell	1,999 -12	-0.6%	-$1.3K	﹤0.01%	1083
2025 Q1	$250K	Buy	2,011 +39	+2%	+$5.09K	﹤0.01%	955
2024 Q4	$243K	Buy	1,972 +97	+5%	+$11.4K	﹤0.01%	996
2024 Q3	$209K	Buy	+1,875	New	+$205K	﹤0.01%	1091
2024 Q2	–	Sell	-2,124	Closed	-$256K	–	1176
2024 Q1	$256K	Buy	2,124 +4	+0.2%	+$490	﹤0.01%	894
2023 Q4	$261K	Sell	2,120 -144	-6%	-$18K	﹤0.01%	863
2023 Q3	$293K	Buy	2,264 +121	+6%	+$16.1K	﹤0.01%	802
2023 Q2	$266K	Buy	2,143 +2	+0.1%	+$269	﹤0.01%	843
2023 Q1	$313K	Buy	+2,141	New	+$317K	﹤0.01%	796
2015 Q3	–	Sell	-81,798	Closed	-$14.4M	–	957
2015 Q2	$14.4M	Sell	81,798 -2,242	-3%	-$403K	0.1%	87
2015 Q1	$14.5M	Sell	84,040 -2,183	-3%	-$375K	0.1%	84
2014 Q4	$14.1M	Sell	86,223 -20,136	-19%	-$3.34M	0.09%	85
2014 Q3	$17.1M	Buy	106,359 +2,789	+3%	+$429K	0.1%	83
2014 Q2	$15.2M	Buy	103,570 +1,350	+1%	+$187K	0.09%	102
2014 Q1	$14.2M	Buy	+102,220	New	+$15.4M	0.08%	103

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

CIBC Asset Management's JAZZ Position: Q2 2026 in Review

CIBC Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.8% in Q2 2026, selling an estimated $20.8K and leaving 1,904 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #857.

CIBC Asset Management first reported a position in JAZZ in Q1 2014 and has held it in 19 quarters since. The position peaked at $17.1M in Q3 2014. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

CIBC Asset Management held 1,904 shares of Jazz Pharmaceuticals worth $459K as of Q2 2026.
CIBC Asset Management sold 95 Jazz Pharmaceuticals shares in Q2 2026, an estimated $20.8K.
Jazz Pharmaceuticals made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #857 holding.
CIBC Asset Management first reported a position in Jazz Pharmaceuticals in Q1 2014 and has held it in 19 quarters since.
CIBC Asset Management's Jazz Pharmaceuticals position peaked at $17.1M in Q3 2014.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.